Many plant RNA viruses provide replication and encapsidation functions for one or more satellite RNAs (sat-RNAs) that can modulate the symptoms of the associated helper virus. Sat-RNA C, a virulent sat-RNA associated with turnip crinkle virus (TCV), normally intensifies symptoms but can attenuate symptoms if the TCV coat protein (CP) is replaced with that of cardamine chlorotic fleck carmovirus ) Plant Cell 7, 1625-1634 or if TCV contains an alteration in the CP initiation codon (TCV-CPm) [Kong et al. (1997b ) Plant Cell 9, 2051-2063. To further elucidate the mechanism of symptom attenuation by sat-RNA C, the composition of the CP produced by TCV-CPm (CP CPm ) was determined. Our results reveal that CP CPm likely has two additional amino acids at its N-terminus compared with wild-type TCV CP. TCV-CPm produces reduced levels of CP, and this reduction, not the two additional residues at the CP N-terminus, is responsible for symptom attenuation by sat-RNA C.
INTRODUCTION
Many plant RNA viruses are associated with one or more nonessential RNAs, such as defective interfering RNAs and satellite RNAs (sat-RNAs). These subviral RNAs depend on the helper virus for replication, encapsidation, and movement through the plant. The sat-RNAs range in size from 194 to 1500 nucleotides (nt) and usually have sequence unrelated to the viral genome. As molecular parasites of their helper viruses, sat-RNAs frequently modulate viral symptom expression. The smaller sat-RNAs (194-700 nt), including those of cucumber mosaic virus (CMV) and turnip crinkle virus (TCV), do not encode any functional open reading frames (ORFs) (Roossinck et al., 1992) . However, despite the absence of gene products, these sat-RNAs can have dramatic effects on the symptoms induced by their helper viruses (for reviews, see Kaper and Collmer, 1988; Simon, 1988; Collmer and Howell, 1992) . Many viral sat-RNAs attenuate disease (e.g., satellites of CMV and tobacco ringspot virus), a property of interest for viral disease control (Gerlach et al., 1987; Harrison et al., 1987; Tien and Wu, 1991) . However, some satellites exacerbate symptoms of their helper virus. One such sat-RNA is sat-RNA C associated with TCV (Li and Simon, 1990) .
Some viruses are associated with several sat-RNAs that differentially modulate symptoms (Murant and Kumar, 1990; Blok et al., 1994; Celix et al., 1997) . Identical sat-RNAs can also have different effects on symptoms when associated with different helper virus strains (Kaper et al., 1990; Sleat and Palukaitis, 1990b; Roossinck et al., 1992; Sleat et al., 1994; Kong et al., 1997a; Militao et al., 1998) . Furthermore, the same sat-RNA/helper virus combination can have different effects in different hosts. For example, symptoms of CMV are intensified by some CMV sat-RNAs, resulting in either chlorosis in tomato and tobacco (Palukaitis, 1988) or necrosis in tomato (Takanami, 1981; Sleat et al., 1994) . Therefore, sat-RNAmediated symptom modulation is determined by a trilateral interaction among the satellite, helper virus, and host plant. Many sat-RNA sequences that mediate symptom modulation have been defined Palukaitis, 1988; Baulcombe et al., 1988; Kurath and Palukaitis, 1989; Masuta and Takanami, 1989; Jaegle et al., 1990; Palukaitis, 1990a, 1990b; Naidu et al., 1992; Sleat et al., 1994; Zhang et al., 1994; Oncino et al., 1995; Kong et al., 1997a; Rodriguez-Alvarado and Roossinck, 1997; Taliansky and Robinson, 1997) . In contrast, the role of the helper virus and host plant is poorly understood.
We are studying symptom modulation of TCV by sat-RNA C in the host plant Arabidopsis thaliana. TCV is a member of the Carmovirus genus and is the only genus member that is associated with confirmed sat-RNAs. TCV has a single plus-sense RNA genome of ϳ4 kb (Carrington et al., 1989; Oh et al., 1995) and two subgenomic (sg) RNAs of 1.72 and 1.45 kb (Carrington et al., 1987; Wang and Simon, 1997) (Fig.  1A) . The viral genomic RNA is the mRNA for p28 and its readthrough product p88, which are required for viral rep-lication. Two small ORFs (p8 and p9) that are implicated in viral movement (Hacker et al., 1992; Li et al., 1998) can be translated from the 1.72-kb sgRNA in vitro (Li et al., 1998) . The 1.45-kb sgRNA is the mRNA for the 38-kDa coat protein (CP) (Carrington et al., 1989) . The TCV virion is icosahedral in structure with T ϭ 3 symmetry and is composed of 180 copies of the CP (Hogle et al., 1986; Carrington et al., 1989) .
TCV systemically infects all ecotypes of A. thaliana tested except for ecotype Di-0 (Simon et al., 1992) . TCV can replicate in protoplasts of Di-0 but cannot move systemically in whole plants (Simon et al., 1992) . When the CP ORF of TCV was replaced with that of the related carmovirus cardamine chlorotic fleck, the resulting chimeric virus (TCV-CP CCFV ) systemically infected Di-0, indicating that the CP ORF or the CP is an important viral determinant in the resistance of Di-0 to TCV Kong et al., 1995) . TCV with a single mutation in the initiation codon of the CP ORF (TCV-CPm; Fig. 1A ) also overcomes the resistance of Di-0, suggesting that the CP, as opposed to the RNA encoding the CP, is the most likely elicitor of resistance to wild-type (wt) TCV in Di-0.
Sat-RNA C is a hybrid sat-RNA consisting of a nearly full-length avirulent sat-RNA (sat-RNA D) at the 5Ј end joined to two regions from the 3Ј end of TCV genomic RNA (Fig. 1B) . Sat-RNA C can either intensify or attenuate symptoms depending on the helper virus. Sat-RNA C intensifies symptoms of wt TCV on all hosts where TCV produces visible symptoms (Li and Simon, 1990) . In susceptible ecotypes of A. thaliana, the moderate stunting symptoms of TCV are exacerbated by sat-RNA C, resulting in the death of the plant by ϳ16 days postinoculation (p.i.) (Li and Simon, 1990; Simon et al., 1992) . Whole plant in situ hybridizations indicate that the TCV genomic RNA becomes concentrated in younger tissue in the presence of sat-RNA C, leading to an inhibition of bolting and plant death (Kong, 1996) . On hosts that are tolerant to TCV infection (and therefore have no symptoms associated with virus infection), the presence of sat-RNA C has no effect on plant symptomatology (Li and Simon, 1990) .
Although sat-RNA C intensifies the symptoms of wt TCV, it attenuates the symptoms of TCV-CP CCFV . sat-RNA C also attenuates the symptoms of ϳ70% of plants inoculated with TCV-CPm. Attenuation of symptoms directly correlates with undetectable levels of viral genomic RNA in extracts of whole plants (Kong et al., 1997a (Kong et al., , 1997b . Because TCV-CPm differs from TCV by only a single base alteration in the CP initiation codon, the CP and not the RNA encoding the CP is most likely the viral determinant associated with sat-RNA C symptom modulation (Kong et al., 1997a) .
Plants and protoplasts infected with TCV-CPm accumulate ϳ20% of wt levels of a protein that migrates to a similar position as wt TCV CP (CP WT ) in polyacrylamide gels and cross-reacts with CP-specific antibodies (Kong et al., 1997b) . Virions, however, are nearly undetectable in preparations of TCV-CPm-infected protoplasts (Kong et al., 1997b) . The inability to isolate comparable levels of virions based on the amount of CP present in cells could be due to CP levels being below the threshold required for virion formation. Alternatively, the TCV-CPm CP (CP CPm ) may be incapable of efficient virion formation due to translation initiating near, but not at, the natural initiation codon, resulting in a mutant N-terminus. Furthermore, the ability of sat-RNA C to attenuate TCV-CPm symptoms could be due to the presence of reduced levels of CP, the absence of virions, and/or putative alterations to the N-terminus of CP CPm .
To distinguish between these possibilities and to further our understanding of symptom modulation by sat-RNA C, the possible initiation codon of CP CPm was characterized. Our results suggest that translation of CP CPm likely initiates at an in-frame non-AUG codon (CUG) upstream from the normal initiation codon resulting in two additional amino acids at the CP CPm N-terminus. In addition, reduced levels of CP, not alterations to the N-terminus, are the principal determinant of symptom attenuation by sat-RNA C. Possible models are proposed to explain how CP levels may be involved in symptom attenuation by sat-RNA C in the TCV/Arabidopsis system. was thought to initiate at or near the wt initiation codon. Because the nearest in-frame AUGs in the TCV CP mRNA are either 42 amino acids upstream followed by two stop codons or 40 amino acids downstream from the wt initiation codon and because all nearby out-of-frame AUG triplets are followed by stop codons, CP CPm is likely synthesized beginning with a noncanonical initiation codon such as the ACG at the wt initiation position or an in-frame CUG codon located six nucleotides upstream ( Fig. 2A) . Noncanonical translation initiation has been confirmed or suggested for several cellular mRNAs (Beams et al., 1991; Saris et al., 1991) and viral RNAs from plant (Schmitz et al., 1996) and animal (Mehdi et al., 1990; Reynolds et al., 1995) hosts (for reviews, see Gallie, 1993; Rohde et al., 1994) . Translation was previously reported to initiate from ACG and CUG with 15% and 30% efficiency, respectively, compared with AUG in plant cells (Gordan et al., 1992) .
To determine whether the ACG or CUG might serve as initiation codons for CP CPm , mutations were introduced into the analogous positions of these nucleotides in TCV-CPm cDNA. As shown in Fig. 2A , the ACG codon 6 ) were inoculated with 20 g of wt TCV or mutant transcripts. Total RNA was subjected to RNA gel blot analyses using a probe specific for TCV genomic RNA (gRNA) and sgRNAs (1.72 and 1.45 kb) (see Table 1 ) or rRNAs (Simon et al., 1992) . CP and virions (v) was altered to AGG generating CPm-L and the CUG codon was changed to UUG generating CPm-T. CPm-O was generated by combining both new mutations into a single construct. Neither of the resultant triplets (AGG or UUG) initiates translation in either mammalian or plant cells (Gallie, 1993; Rohde et al., 1994) . Transcripts synthesized in vitro representing CPm-L, CPm-T, and CPm-O were inoculated onto A. thaliana protoplasts, and total RNA, protein, and virions were extracted 40 h p.i. for examination of viral RNA accumulation, CP synthesis, and virion formation.
RNA gel blot analysis revealed that CPm-L and CPm-T replicated to near wt levels, whereas TCV-CPm replicated to a lower level (Fig. 2B ) as previously described (Kong et al., 1997b; note, however , that the TCV-CPm sample is underloaded according to the corresponding rRNA levels in Fig. 2B ). It is not known why CPm-L and CPm-T had higher levels of genomic RNA replication compared with the parental mutant TCV-CPm. Surprisingly, no viral RNA was detected in CPm-O-infected protoplasts. This was unexpected because the mutations introduced into CPm-O are outside the viral p28 and p88 ORFs and are not within promoters known to be required for replication (Hacker et al., 1992; Wang and Simon, 1997) . In addition, previous studies have shown that TCV genomic RNA accumulates in the absence of the majority of the CP ORF, including this region . However, the possibility cannot be ruled out that there is an additional mutation in some other critical location within the genome of CPm-O.
Western blot analysis using antibodies raised against CP WT revealed that protoplasts infected with TCV-CPm accumulated 23% of wt levels of CP and no detectable virions as previously reported ( Fig. 2B ; Kong et al., 1997b) . Protoplasts infected with CPm-L, which maintains the CUG codon but not the ACG codon, accumulated 35% of wt levels of CP. In addition, like TCV-CPm, no virions were detected in CPm-L-infected protoplasts (Fig. 2B) . In contrast, no CP was detected in protoplasts infected with CPm-T, which maintains the ACG codon but not the CUG codon (Fig. 2B) . As expected, no CP was synthesized in CPm-O-infected protoplasts due to the lack of viral RNA accumulation (Fig. 2B) . These results suggest that the CUG is likely the initiation codon for translation of CP CPm .
To determine whether CPm-L mimics TCV-CPm in infectivity and symptom modulation by sat-RNA C, A. thaliana ecotypes Col-0 and Di-0 were inoculated with TCV, TCV-CPm, and CPm-L, with or without sat-RNA C. Symptoms were assessed visually at various times up to 17 days p.i. As shown in Fig. 2C , CPm-L, like TCV-CPm, was infectious on both Col-0 and Di-0, and unlike TCV, which only infects Col-0. In addition, symptoms of CPm-L were delayed by 1-2 days compared with wt TCV, similar to the symptom delay from inoculation with TCV-CPm. Coinoculation with sat-RNA C resulted in 70% of the plants inoculated with CPm-L remaining either symptomless (Col-0) or exhibiting attenuated symptoms (Di-0) at 17 days p.i. (Fig. 2C ; plants that did not have attenuated symptoms exhibited systemic symptoms similar to those of plants inoculated with only the genomic RNA). No symptoms developed in either CPm-T-or CPm-O-infected plants, with or without sat-RNA C (data not shown). Because TCV requires its CP for systemic movement in plants (Hacker et al., 1992) , the inability of CPm-T to infect plants was most likely due to the lack of CP synthesized during the infection.
Taken together, these results suggest that the CUG six nucleotides upstream of the wt initiation codon is the most likely initiation codon used in translating CP CPm . Because methionine appears to be the initiating amino acid in all noncanonical translation initiations investigated so far (Gupta and Patwardhan, 1988; Curran and Kolakofsky, 1988; Hann et al., 1988; Peabody, 1989) , there probably are two additional amino acids (glutamic acid and threonine) at the N-terminus of CP CPm compared with CP WT (Fig. 3A) . These additional amino acids could account for the slightly slower migration of CP CPm compared with CP WT , which is visible on most polyacrylamide gels (see Fig. 3B , for example).
TCV producing wt levels of CP with two additional N-terminal amino acids abolishes symptom attenuation by sat-RNA C To determine whether lack of detectable virions and symptom attenuation by sat-RNA C when associated with TCV-CPm is due to the two putative amino acids at the N-terminus of the CPs and/or the reduced levels of CP, the effect of wt levels of mutant CP on symptom modulation and virion formation were investigated. To obtain wt levels of this mutant CP, nucleotides specifying the two extra amino acids likely found in CP CPm were inserted after the initiator AUG of the CP ORF in wt TCV generating TCV-CPm3 (Fig. 3A) .
Transcripts synthesized in vitro were inoculated onto A. thaliana protoplasts, and total RNA extracted at 40 h p.i. was subjected to RNA gel blot analysis. As shown in Fig. 3B , TCV-CPm3 replicated to near wt levels (note that the TCV-CPm3 sample was underloaded according to the level of rRNA). Western blot analyses of total protein and virion preparations at 40 h p.i. revealed that TCVCPm3 produced levels of CP comparable to wt TCV and virions were synthesized (Fig. 3B) . The CP of TCV-CPm3 comigrated with CP CPm at a position slightly slower than CP WT (Fig. 3B) , supporting the hypothesis that CP CPm contains similar additional amino acids at its N-terminus. Because CP CPm3 was capable of forming virions, the additional residues at the N-terminus do not by themselves abrogate virion formation.
TCV-CPm3 caused more severe stunting on ecotype Col-0 than wt TCV or TCV-CPm and was able to overcome the resistance of Di-0 to wt TCV (Fig. 3C) . Symp-toms developed concomitantly with those of wt TCV (1-2 days earlier than those of TCV-CPm), probably from either increased CP levels or the presence of virions. Although TCV-CPm3 mimicked TCV-CPm in overcoming the resistance of Di-0 to TCV, coinoculation with sat-RNA C neither attenuated nor intensified the symptoms of TCV-CPm3 (Fig. 3C) . These results indicate that the N-terminus of the CP is important in the resistance of Di-0 to TCV and suggest that the N-terminal mutations by themselves do not abrogate virion formation or cause symptom attenuation of TCV-CPm by sat-RNA C.
Reduced levels of CP WT cause symptom attenuation by sat-RNA C Because the presence of additional amino acids at the N-terminus of the CP do not lead to symptom attenuation by sat-RNA C, the reduced amount of CP synthesized from a noncanonical initiation codon may be the cause of symptom attenuation. If so, then reducing the synthesis of CP in wt TCV infections should affect sat-RNA C symptom modulation.
To reduce the synthesis of CP WT , a GC base pair in the 1.45-kb sgRNA promoter (Wang et al., 1999) was replaced with a weaker GU base pair generating TCV-SGm (Fig.  4A) . The mutation did not alter the p9 ORF where the promoter is located. Five percent of wt levels of the 1.45-kb sgRNA was synthesized according to RNA gel blots of total RNA extracted from TCV-SGm-infected protoplasts at 40 h p.i. (Fig. 4B) . Western blot analysis of total protein extracted from TCV-SGm-infected protoplasts at 40 h p.i. revealed CP WT levels similar to those produced by TCV-CPm (Fig. 4B) . This result suggests that translation initiation from the wt initiator AUG is more efficient than the nearby noncanonical initiator CUG. Virions were also markedly reduced in TCV-SGm-infected protoplasts (Fig. 4B) , suggesting that the amount of CP accumulating in cells is near a threshold level for virion assembly.
To determine whether TCV-SGm mimics TCV-CPm in infectivity and symptom modulation by sat-RNA C, A. thaliana ecotypes Col-0 and Di-0 were inoculated with transcripts of TCV, TCV-CPm, and TCV-SGm, with or without sat-RNA C. Like TCV-CPm, TCV-SGm infected both Col-0 and Di-0 plants, suggesting that virus with reduced levels of CP overcomes the resistance of Di-0 (Fig. 4C) . Symptoms of TCV-SGm on both ecotypes developed concomitantly with TCV-CPm and were slightly more severe than symptoms of TCV-CPm; Di-0 plants infected with TCV-SGm were more stunted and Col-0 plants exhibited increased chlorosis than when infected with TCV-CPm. Although sat-RNA C attenuated the symptoms of 80% of plants inoculated with TCV-SGm at 17 days p.i. in both ecotypes (plants that did not have attenuated symptoms exhibited TCV-SGm-like symptoms; data not shown), symptomless plants never recovered. This result was in contrast with TCV-CPm/sat-RNA C-infected Col-0, in which 70% of plants were symptomless at 17 days p.i.. This result suggests that although reduced CP levels strongly influence sat-RNA-mediated symptom attenua- tion, the effect is more pronounced if the CP contains additional amino acids at its N-terminus.
DISCUSSION
Previous studies demonstrated that sat-RNA C was able to attenuate the symptoms of TCV when the CP initiation codon was changed from AUG to ACG (TCV-CPm; Kong et al., 1997b) . Because lower levels of possibly mutant CP were produced, it was not clear if the attenuation of symptoms by sat-RNA C was due to the reduced levels of CP or the mutant nature of the CP. To address the nature of CP CPm , mutations were introduced into two possible noncanonical in-frame initiation codons in TCV-CPm: the ACG that replaced the wt AUG initiation codon and an upstream in-frame CUG. Converting the ACG to a codon not used for translation initiation (construct CPm-L) did not affect the synthesis of CP, whereas mutating the CUG triplet (construct CPm-T) eliminated CP synthesis (Fig. 2B ). This suggests that CP CPm most likely initiates from the upstream CUG and contains additional glutamic acid and threonine residues at its N-terminus (Fig. 3A) . The presence of these two additional residues correlates with the slightly slower mobility of CP CPm compared with CP WT (Figs. 2B, 3B , and 4B). TCV-CPm3, a mutant virus with glutamic acid and threonine codons inserted after the wt CP initiation codon, synthesized wt levels of a CP that likely has the same two residues at its N-terminus as CP CPm and comigrates with CP CPm on denaturing polyacrylamide gels (Figs. 3A and 3B ). Although TCV-CPm3 mimicked TCVCPm in overcoming the resistance of Di-0 to TCV, symptoms were no longer attenuated by sat-RNA C (Fig. 3C ). This suggests that the two additional residues are not sufficient to induce symptom attenuation by sat-RNA C.
An alternative explanation, which cannot be ruled out, is that we have not yet determined the correct initiation codon for CP CPm and that alteration of the CUG destabilizes the CP. However, this possibility is unlikely because no known noncanonical initiation codons are found any farther upstream before encountering an in-frame termination codon.
To determine whether the reduced levels of CP found in protoplasts infected with TCV-CPm and CPm-L are responsible for symptom attenuation by sat-RNA C, wt TCV genomic RNA was altered to produce less CP WT mRNA (the 1.45-kb sgRNA). TCV-SGm synthesized reduced levels of CP WT in protoplasts, and symptoms were partially attenuated by sat-RNA C in both ecotypes of A. thaliana (Fig. 4C) . This was in slight contrast with TCVCPm, whose symptoms could be completely attenuated by sat-RNA C in Col-0 and partially attenuated in Di-0 (Figs. 2C, 3C , and 4C). These results suggest that the mutant nature of CP CPm contributes to the ability of sat-RNA C to completely attenuate viral symptoms.
The TCV CP is dispensable for replication in protoplasts (Hacker et al., 1992; Kong et al., 1995) , a result confirmed by the near wt accumulation of CPm-T genomic RNA in protoplasts in the absence of detectable CP synthesis (Fig. 2B ). For mutant viruses synthesizing reduced levels of CP (TCV-CPm and CPm-L), the ratios of CP to CP mRNA (the 1.45-kb sgRNA) quantified using densitometry were similar (92% versus 90%). This result suggests that the increased accumulation of CP CPm-L compared with CP CPm in infected protoplasts was due to an increase in virus replication. Because CPm-L produced 35% of wt levels of CP, the inability to detect virions suggests that as with TCV-CPm, either insufficient CP is present for virion nucleation and/or the presence of mutations in the N-terminal region of the CP inhibits virion formation. The RNA binding activity of TCV CP during encapsidation has been suggested to result from electrostatic interactions between the RNA and the N-terminal basic R domain of the CP, which carries a considerable positive charges (Carrington et al., 1987) . CP CPm and CP CPm3 likely have an extra negatively charged residue (E) at the CP N-terminus ( Figs. 2A and 3A) , which could compromise electrostatic interactions, resulting in less encapsidation-competent CP. This could explain why only 80% of wt levels of virions were present in TCV-CPm3-infected protoplasts despite the wt levels of viral RNA and CP (Fig. 3B) . Furthermore, efficient encapsidation requires a highly cooperative assembly interaction between the CP and viral RNA (Skuzeski and Morris, 1995) . Our inability to detect more than trace amounts of TCV-SGm virions (Fig. 4B) suggests that the amount of CP WT synthesized (20% of wt) is near the threshold required for virion formation. Because comparable levels of mutant CP resulted in no detectable virions, nearthreshold amounts of encapsidation-impared CP present in cells infected with TCV-CPm are likely what restrict the formation of virions to undetectable levels (Figs. 2B, 3B, and 4B).
With only a few exceptions (Gardiner et al., 1988; Petty and Jackson, 1990; Dalmay et al., 1992; Scholthof et al., 1993; Xiong et al., 1993; Azzam et al., 1994) , viral CPs are required for systemic infection of plant viruses (Dawson et al., 1988; Sacher and Ahlquist, 1989; Allison et al., 1990; Chapman et al., 1992; Forster et al., 1992; Hacker et al., 1992; Sit and AbouHaidar, 1993; Dolja et al., 1994; Bransom et al., 1995) . However, assembly of CP units into virions may not be necessary for movement of all viruses. Although some studies indicate that virion formation is essential for virus long-distance movement (Saito et al., 1990; Schmitz and Rao, 1998) , other reports (Dalmay et al., 1992; Dolja et al., 1994; Schneider et al., 1997; Kaplan et al., 1998) , including this study, indicate that although the CP is required, virions appear to be dispensable.
Recent studies (Kong et al., 1997a) indicate that the 3Ј-terminal 100 bases of sat-RNA C, which is 90% similar to the analogous region in TCV genomic RNA, is the sat-RNA region involved in symptom modulation. The disappearance or amelioration of TCV symptoms in the presence of sat-RNA C may therefore seem to echo the cosuppression phenomenon found in transgenic plants. Cosuppression occurs when the introduction of a transgene encoding part of or the entire coding sequence of a particular host gene can suppress expression of the transgene and the endogenous host gene (reviewed by Montgomery and Fire, 1998) . However, the mechanism underlying symptom attenuation by sat-RNA C is unlikely to be due to cosuppression for the following reasons: first, sat-RNA C-mediated resistance of A. thaliana to TCV-CPm only moderately affects the level of genomic RNA in inoculated leaves (Kong et al., 1997b) , which is different from the substantial amount of RNA degradation during cosuppression (Lee et al., 1997) ; second, another normally virulent subviral RNA, defective interfering (DI) RNA G, has greater sequence similarity (94%) with the TCV genomic RNA sequence in the 3Ј-terminal region (Kong et al., 1997a) . However, although DI RNA G attenuates the symptoms of TCV-CP CCFV , it does not attenuate the symptoms of TCV-CPm.
Different sat-RNAs may use different mechanisms to attenuate symptoms. In many hosts, disease attenuation by CMV sat-RNAs is accompanied by a reduction in virus accumulation (Kaper and Tousignant, 1977; Kaper and Collmer, 1988) . In contrast, CMV sat-RNA symptom attenuation of tomato aspermy virus is not always accompanied by a noticeable decrease in the level of viral RNAs (Moriones et al., 1992) . Although the attenuation of TCV-CP CCFV symptoms by sat-RNA C was associated with a substantial reduction in virus replication (Kong et al., 1997b) , sat-RNA C attenuation of TCV-CPm symptoms did not involve a large reduction in virus accumulation but rather was associated with a reduction in virus movement (Kong et al., 1997b) . Because virions are not detected in TCV-CPm-infected protoplasts, some other type of viral RNA-CP complex could be engaged in virus movement. Symptom attenuation by sat-RNA C of TCV variants producing reduced levels of CP could therefore result from sat-RNA C competing with the viral genomic RNA for limited amounts of CP, thus reducing or eliminating genomic RNA-CP complexes required for systemic movement of the virus.
A second possibility for how sat-RNA C may attenuate symptoms involves sequestration of factor or factors required for virus movement. Recently, studies have led to suggestions that host factors are involved in trafficking viruses from phloem parenchyma cells into phloem sieve elements and back out, steps required for long-distance virus movement (Schaad and Carrington, 1996; Gilbertson and Lucas, 1996) . The 3Ј end region of sat-RNA C that has recently been shown to be responsible for symptom attenuation (Wang and Simon, manuscript in preparation) may be targeted by either the viral CP or a putative host factor (X) that is involved in virus longdistance movement (Fig. 5) . Regardless of the nature of the interaction between the CP and the 3Ј region of sat-RNA C (i.e., direct or indirect), the presence of high levels of viral CP (as in TCV-or TCV-CPm3-infected plants) may exclude the binding of X to the 3Ј end of the sat-RNA C. Therefore, the putative X is available to help viral RNA move systemically through the plant (Fig. 5A) . In contrast, in the presence of reduced levels of CP (as in TCV-CPm-, CPm-L-, or TCV-SGm-infected plants), X is able to outcompete the CP for binding to the 3Ј-terminus of sat-RNA C, and sequestration of X by sat-RNA C could lead to restriction of virus long-distance movement and result in symptom attenuation (Fig. 5B) . On the other hand, when TCV-CP CCFV is the helper virus, the CCFV CP (which shares only 65% identity with CP WT ; Oh et al., 1995) may not recognize the 3Ј end of sat-RNA C, allowing X to bind and resistance to be mediated (Fig. 5C ). Studies to distinguish between possible models are currently under way.
The susceptibility of Di-0 to TCV-CPm and TCV-CPm3 suggests that the N-terminus of the CP is important for the resistance of Di-0 to TCV. In addition, the susceptibility of Di-0 to TCV-SGm suggests that reducing the levels of wt CP can also eliminate resistance. In addition to its role in resistance, the TCV CP also contributes to expression of symptoms. The symptoms of TCV-CPm3 were more severe than those of TCV in Col-0, even though similar levels of viral RNA and CP were synthesized in protoplasts (Fig. 3) . This suggests that mutations at the N-terminus of the CP exacerbate symptoms. The multifunctional nature of viral CPs may be due to multiple determinants that can be hidden (or exposed) by changes in the structure or quantity of the protein. This property of CPs has been demonstrated for tobacco mosaic virus: a reduction of subunit interactions was hypothesized to expose a site on the CP that interacts with the NЈ gene product of tobacco, resulting in hypersensitive resistance (Culver et al., 1994) . It is also possible that virions themselves elicit more severe symptoms, whereas the CP monomer does not elicit such a response. This could explain why TCV, TCV-CPm3 (Fig.  3) , and TCV-SGm (Fig. 4) caused more severe symptoms than TCV-CPm and CPm-L (Fig. 2) .
MATERIALS AND METHODS

Virus strains and plasmid constructions
Plasmids containing full-length cDNAs of TCV (pT7TCVms; Oh et al., 1995) , sat-RNA C [pT7satC(ϩ); Song and Simon, 1994] , and TCV-CPm (pT7TCV-CPm; Kong et al., 1997) downstream from a T7 RNA polymerase promoter have been described.
For construction of plasmids CPm-L, CPm-T, and CPm-O, oligonucleotide CPm-LTO, containing degenerate nucleotides in its sequence (all the oligonucleotides are listed in Table 1 ), was used with oligonucleotide OL3270C(ϩ) in a polymerase chain reaction (PCR) using pT7TCV-CPm as template. A second PCR was performed with oligonucleotides 1.7LB and OL2736C(ϩ). The PCR products were digested with BsmI and EcoRI, respectively, and the larger fragments were purified and combined. The mixture was then ligated to pT7TCVms that had been previously digested with BsmI and EcoRI. Plasmid TCV-CPm3 was generated in a similar fashion except that oligonucleotide CPm-LTO was replaced with CPm3C(Ϫ). Plasmid TCV-SGm was generated in a similar fashion except that the template and oligonucleotide CPm-LTO were replaced with pT7TCVms and OL2604C(Ϫ), respectively, and the second PCR was performed with oligonucleotides SGmC(ϩ) and RV-1C(Ϫ).
Plant growth and inoculations
Plants (A. thaliana ecotypes Col-0 and Di-0) were grown in growth chambers at 20°C as described by Li and Simon (1990) . Plant seedlings at the six-to eight-leaf stage were mechanically inoculated on the oldest leaf pair as described previously (Kong et al., 1997b) with 0.1 mg/ml full-length transcripts synthesized in vitro from cloned cDNAs using T7 RNA polymerase . For experiments examining the effects of sat-RNA C on symptom modulation, 0.01 mg/ml of full-length transcripts synthesized from the cloned cDNA of sat-RNA C was included in the inoculum.
Preparation and inoculation of A. thaliana protoplasts
Protoplasts were prepared from Col-0 callus cultures as described (Kong et al., 1997b) . Protoplasts (5 ϫ 10 6 ) were inoculated with 20 g of genomic RNA transcripts synthesized in vitro as previously described (Kong et al., 1997b) .
Protein gel blot analysis
Total proteins were extracted from protoplasts by vortexing the cells in an equal volume of extraction buffer [125 mM Tris⅐HCl, pH 6.8, 0.1% SDS, and 20% glycerol (v/v)] followed by centrifugation at 10,000 rpm for 5 min in a microcentrifuge to collect the supernatants. Total protein or isolated virions were separated on either 12% SDS-polyacrylamide gels or 1% agarose gels, respectively, containing 50 mM Tris base/38 mM glycine, pH 8.3, as previously described (Heaton, 1992) . Total protein or virions were transferred to NitroPlus membrane (Micron Separations Inc., Westborough, MA) as previously de- scribed (Kong et al., 1997b) . Protein gel blot analysis was performed as described by Ausubel et al. (1987) with some modifications as described by Kong et al. (1997b) .
Virion isolation and analysis
Virus particles were isolated from infected protoplasts as previously described (Qu and Morris, 1997) with modifications described by Kong et al. (1997b) . Virus particles were analyzed by electrophoresis through 1% agarose gels prepared in 50 mM Tris base/38 mM glycine, pH 8.3, as previously described (Laakso and Heaton, 1993) followed by protein gel blot analysis as described above.
RNA gel blot analysis
Four micrograms of total RNA isolated from protoplasts (Simon et al., 1992) were denatured by heating in 50-70% formamide and then subjected to electrophoresis through nondenaturing 1.5% agarose gels. RNA was then transferred to NitroPlus membrane (Micron Separations Inc.) and subjected to hybridization with an oligonucleotide probe specific for TCV (Table 1) or a probe specific for plant ribosomal RNAs (Simon et al., 1992) as previously described (Wang and Simon, 1997) .
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